Newsletter Subscribe
Enter your email address below and subscribe to our newsletter
Enter your email address below and subscribe to our newsletter

AcrivaUD Trinova Comes to the Fore with its Four Main Features The world’s first and only sinusoidal trifocal iol Acrivaud trinova used by ophthalmologists in 64 countries across the world to correct cataracts and for refractive lens exchange attracts more…

Corcoran Consulting Group (CCG) and Conclusn have teamed up to create a software application that provides proprietary utilization benchmarks for ophthalmic procedures. Practice managers can use the application to identify lost income opportunities and related compliance problems. According to a…

Retina Consultants of America (RCA), a physician management services organization, has added Retina Center Northwest (RCNW) in Washington state,. Financial terms of the deal were not disclosed. With the addition of RCNW, RCA adds to its presence in the Pacific…

Contract research organization TFS HealthScience announced it has acquired Appletree CI Group, a CRO and global regulatory affairs service provider. The terms of the deal were not disclosed. The deal expands the global reach for clients while enhancing TFS HealthScience’s…

Johnson & Johnson Vision goes to court against Alcon for its intellectual property rights. Alcon and J&J Vision are facing off in the U.S. District Court, District of Delaware, No. 20-cv-00842. After a US District judge rules against request for…

When Alexander Graham Bell brought us the revolutionary first ever telephone back in 1876, the world was changed forever. Ever since then, telephonic devices have been a mainstay of the modern world; an essential part of our everyday lives. Of…

STADA Arzneimittel AG and Xbrane Biopharma AB announced that the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has approved Ximluci® (ranibizumab), a biosimilar of Lucentis®. STADA plans to launch Ximluci in the United Kingdom in 2023. Xbrane’s contribution to…

Viatris announced the completion of its acquisitions of Oyster Point Pharma and Famy Life Sciences to establish a new Viatris Eye Care Division. On November 7, the purchase was originally announced. Jeffrey Nau, PhD, MMS, former CEO of Oyster Point…

Italy-based Sifi formed a collaboration with Avanzanite Bioscience, a Dutch specialty pharmaceutical business, to commercialize and distribute Akantior (polihexanide) exclusively in 26 European Economic Area and Swiss countries. Sifi will manage all ongoing regulatory activities under the terms of the…

Elios Vision stated that its Elios technology, which is used to treat glaucoma concurrently with cataract surgery, is officially registered in the United Kingdom. The Elios does not require an implant and is designed to provide long-lasting results that may…